-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Skylight Health Announces Extension of Final Tranche of Previously Announced US$5 Million Financing
Skylight Health Announces Extension of Final Tranche of Previously Announced US$5 Million Financing
TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) ("Skylight Health" or the "Company"), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announces that the Company has been granted an extension by the TSX Venture Exchange (the "TSXV") to complete the final tranche of the previously announced US$5 million financing in the form of convertible debentures ("Financing") by no later than December 21, 2022.
The terms of the Financing remain unchanged from those described in the press release dated October 21, 2022, found here, and the Financing remains subject to receipt of all necessary approvals, including the approval of the TSXV.
About Skylight Health Group
Skylight Health Group (TSXV:SLHG; OTCQX: SLHGF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service ("FFS") model to value-based care ("VBC") through tools including proprietary technology, data analytics and infrastructure. In an FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on the volume of patients per day. In a VBC model, the providers offer care that is aimed at keeping patients healthy and minimizing unnecessary health expenditures that are not proven to maintain the patient's well-being. This places emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.
Forward Looking Statements
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent our current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this release. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as "look forward," "believe," "continue," "building," or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings we make with the Canadian securities regulators, and Canadian Securities Administrators, available at , and on our website, at skylighthealthgroup.com.
For more information, please visit our website or contact:
Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com416-301-2949
TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) ("Skylight Health" or the "Company"), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announces that the Company has been granted an extension by the TSX Venture Exchange (the "TSXV") to complete the final tranche of the previously announced US$5 million financing in the form of convertible debentures ("Financing") by no later than December 21, 2022.
多倫多,2022年11月21日(環球社)--天光健康集團(多倫多證券交易所股票代碼:SLHG;OTCQX:SLHGF)(“天光健康”或“公司”),一家結合技術和分析的醫療保健平臺,專注於將患者過渡到基於價值的護理,以推動美國更好的健康結果和體驗,今天宣佈,該公司已獲得多倫多證券交易所風險交易所(The TSX Venture Exchange)的延期。TSXV“)完成之前宣佈的500萬美元可轉換債券融資的最後一批(”融資“)不遲於2022年12月21日。
The terms of the Financing remain unchanged from those described in the press release dated October 21, 2022, found here, and the Financing remains subject to receipt of all necessary approvals, including the approval of the TSXV.
融資條款與日期為2022年10月21日的新聞稿中描述的條款保持不變,可在此處找到,融資仍需獲得所有必要的批准,包括TSXV的批准。
About Skylight Health Group
關於天光健康集團
Skylight Health Group (TSXV:SLHG; OTCQX: SLHGF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service ("FFS") model to value-based care ("VBC") through tools including proprietary technology, data analytics and infrastructure. In an FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on the volume of patients per day. In a VBC model, the providers offer care that is aimed at keeping patients healthy and minimizing unnecessary health expenditures that are not proven to maintain the patient's well-being. This places emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.
Skylight Health Group(TSXV:SLHG;OTCQX:SLHGF)是一家醫療服務和技術公司,致力於積極影響患者的健康結果。該公司經營着美國多個州的初級保健保健網絡,由物理實踐組成,提供從初級保健、專科、聯合保健和實驗室/診斷測試在內的一系列服務。該公司專注於幫助小型和獨立的業務從傳統的按服務收費("FFS")從模式到基於價值的護理("VBC")通過專有技術、數據分析和基礎設施等工具。在FFS模式中,付款人(商業和政府保險公司)根據相遇的方法進行報銷。這將重點放在每天的病人數量上。在VBC模式中,提供者提供的護理旨在保持患者的健康,並將未經證明能夠維持患者福祉的不必要的醫療支出降至最低。這把重點放在質量上,而不是數量上。VBC將改善患者的預後,降低交付成本,並從現有實踐中推動更強勁的財務業績。
Forward Looking Statements
前瞻性陳述
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent our current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this release. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as "look forward," "believe," "continue," "building," or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings we make with the Canadian securities regulators, and Canadian Securities Administrators, available at , and on our website, at skylighthealthgroup.com.
本新聞稿可能包括可能被視為適用證券法意義上的前瞻性的預測、估計或其他信息。雖然這些前瞻性陳述代表了我們目前的判斷,但它們會受到風險和不確定性的影響,這些風險和不確定性可能會導致實際結果大不相同。告誡您不要過度依賴這些前瞻性陳述,這些陳述僅反映我們截至本新聞稿發佈之日的觀點。請記住,我們沒有義務根據新信息或未來事件修改或公開發布對這些前瞻性陳述的任何修訂結果。在此使用時,諸如“展望”、“相信”、“繼續”、“建設”等詞語或此類詞語的變體和類似表達旨在識別前瞻性陳述。在我們向加拿大證券監管機構和加拿大證券管理人提交的文件中,經常討論可能導致實際結果與我們在此作出的任何前瞻性聲明中預期的結果大不相同的因素,這些文件可在我們的網站skylighthealthgroup.com上獲得。
For more information, please visit our website or contact:
欲瞭解更多信息,請訪問我們的網站或聯繫:
Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com416-301-2949
投資者關係:
傑基·凱利
電子郵件:Investors@skylighthealthgroup.com416-301-2949
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧